Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications

Citation
Dj. Mckenna et al., Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications, ALTERN TH H, 7(5), 2001, pp. 70
Citations number
127
Categorie Soggetti
Health Care Sciences & Services
Journal title
ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE
ISSN journal
10786791 → ACNP
Volume
7
Issue
5
Year of publication
2001
Database
ISI
SICI code
1078-6791(200109/10)7:5<70:ESAUOG>2.0.ZU;2-J
Abstract
Ginkgo biloba is a dioecious tree with a history of use in traditional Chin ese medicine, Although the seeds are most commonly employed in traditional Chinese medicine, in recent years standardized extracts of the leaves have been widely sold as a phytomedicine in Europe and as a dietary supplement i n the United States. The primary active constituents of the leaves include flavonoid glycosides and unique diterpenes known as ginkgolides; the latter are potent inhibitors of platelet activating factor. Clinical studies have shown that ginkgo extracts exhibit therapeutic activity in a variety of di sorders including Alzheimer's disease, failing memory, age-related dementia s, poor cerebral and ocular blood flow, congestive symptoms of premenstrual syndrome, and the prevention of altitude sickness. Due in part to its pote nt antioxidant properties and ability to enhance peripheral and cerebral ci rculation, ginkgo's primary application lies in the treatment Of cerebrovas cular dysfunctions and peripheral vascular disorders.